Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Marked Response to Nivolumab by a Patient With SMARCA4‐De... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Marked Response to Nivolumab by a Patient With SMARCA4‐Deficient Undifferentiated Urothelial Carcinoma Showing High PD‐L1 Expression: A Case Report
0
Authors
Yohei Arihara
8 more
Yohei Arihara
•
Ginji Omori
6 more
•
Kohichi Takada
Published
June 1, 2024
Paper
Conversation
0
Reviews
0
Bounties
0
Sign in to comment
Add a comment...
Best
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Cancer Reports
Topics
Biology
Biochemistry
Medicine
Cancer Oncology
Epidemiology
Show all topics
DOI
10.1002/cnr2.2127
License
CC-BY
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Cancer Reports
Topics
Biology
Biochemistry
Medicine
Cancer Oncology
Epidemiology
Show all topics
DOI
10.1002/cnr2.2127
License
CC-BY
